fat
embol
syndrom
fe
sever
potenti
lifethreaten
complic
long
bone
fractur
mortal
rate
rang
report
incid
fe
differ
studi
vari
mani
patient
long
bone
fractur
suffer
subclin
hypoxemia
remain
undiagnos
patient
clinic
inappar
hypoxemia
remain
undetect
may
present
clinic
fe
follow
surgeri
definit
stabil
fractur
though
embol
fat
globul
follow
long
bone
fractur
common
event
fe
occur
result
damag
interstiti
alveolar
inflamm
trigger
lipid
metabolit
blood
circul
lowdos
corticosteroid
given
skelet
trauma
believ
prophylact
effect
incid
fat
embol
syndrom
arteri
hypoxemia
reduc
inflammatori
respons
howev
due
apprehens
complic
system
use
steroid
use
prophylaxi
fe
still
limit
risk
delay
wound
heal
infect
trauma
patient
steroid
therapi
aerosol
therapi
modal
drug
administr
main
advantag
given
therapeut
respons
drug
dose
severalfold
lower
system
absorpt
neglig
aerosol
prepar
steroid
advantag
better
pulmonari
deposit
effici
high
system
clearanc
select
bind
glucocorticoid
receptor
efficaci
inhal
corticosteroid
alreadi
prove
parenchym
lung
injuri
due
chlorin
ga
acut
respiratori
distress
syndrom
ciclesonid
inhal
corticosteroid
administ
via
metereddos
inhal
mdi
reach
lung
parenchyma
unlik
previou
steroid
inhal
unabl
go
beyond
bronchial
tree
minim
effect
endogen
cortisol
alreadi
use
success
treatment
allerg
rhiniti
asthma
fe
primarili
lung
parenchyma
disord
expect
ciclesonid
aerosol
given
prophylaxi
may
abl
stabil
lung
parenchyma
also
suppos
bear
effect
posttraumat
fat
globulinemia
prevent
develop
hypoxemia
fe
highrisk
patient
date
publish
studi
impact
inhal
steroid
prophylaxi
fe
studi
design
evalu
role
inhal
corticosteroid
prevent
fat
embol
syndrom
highrisk
patient
studi
conduct
period
two
year
follow
approv
institut
review
board
postgradu
institut
medic
educ
research
pgimer
chandigarh
india
specif
approv
number
assign
time
inform
patient
consent
obtain
prior
treatment
select
patient
studi
made
attend
surgic
emerg
institut
patient
belong
age
group
year
fractur
femor
shaft
alon
associ
skelet
injuri
present
within
eight
hour
injuri
consid
inclus
patient
multisystem
trauma
signific
head
chest
abdomin
injuri
open
femor
fractur
patholog
fractur
preexist
cardiac
pulmonari
diseas
chronic
smoker
exclud
obtain
inform
consent
patient
either
sex
randomli
select
studi
patient
initi
resuscit
necessari
splint
appropri
imag
skelet
injuri
done
investig
time
admiss
includ
chest
roentgenogram
arteri
blood
ga
analysi
abg
hemoglobin
hematocrit
platelet
count
serum
biochemistri
blood
glucos
level
serum
lactat
coagul
profil
select
patient
put
one
two
group
depend
upon
random
alloc
number
earliest
possibl
time
admiss
hospit
patient
alloc
group
given
ciclesonid
mcg
meter
dose
inhal
steroid
dose
repeat
hour
patient
alloc
group
given
steroid
taken
control
studi
patient
irrespect
studi
group
taken
surgic
stabil
fractur
per
convent
manag
protocol
patient
monitor
three
day
irrespect
intermedi
surgic
intervent
complet
record
maintain
repeat
clinic
evalu
includ
four
hourli
vital
puls
rate
respiratori
rate
blood
pressur
temperatur
hourli
abg
estim
hour
three
day
daili
chest
xray
hemogram
coagul
profil
taken
note
made
side
effect
inhal
steroid
observ
hospit
admiss
period
eg
oropharyng
candidiasi
alter
serum
biochemistri
wound
complic
outcom
assess
document
episod
hypoxemia
within
hour
observ
period
fat
embol
index
score
patient
calcul
daili
blind
investig
base
schonfeld
et
al
criteria
petechia
sensit
indic
fe
follow
hypoxaemia
arteri
oxygen
partial
pressur
lower
mmhg
posit
xray
find
patient
subclin
fe
identifi
score
less
five
episod
hypoxia
diagnos
serial
arteri
blood
ga
estim
diagnosi
subclin
hypoxemia
patient
classifi
six
subgroup
three
control
three
trial
group
accord
valu
consid
hypoxaemia
mmhg
classifi
patient
three
categori
sever
hypoxaemia
mmhg
mild
hypoxaemia
mmhg
mmhg
normal
mmhg
analysi
done
compar
incid
hypoxemia
fe
group
determin
effect
prophylact
dose
inhal
steroid
statist
analysi
done
use
mannwhitney
test
quantit
data
chisquar
test
qualit
data
pvalu
less
consid
statist
signific
first
group
male
eight
femal
mean
age
year
rang
year
wherea
control
group
male
seven
femal
averag
age
year
rang
year
variabl
compar
group
time
admiss
followup
age
sex
prehospit
stabil
fractur
splint
time
sinc
injuri
arriv
hospit
vital
paramet
statist
insignific
group
signific
associ
partial
pressur
oxygen
hemoglobin
haematocrit
biochem
paramet
time
admiss
subsequ
develop
fe
group
six
patient
subclin
fe
group
although
eight
case
clinic
fe
control
group
three
case
ciclesonid
prophylaxi
group
statist
insignific
thu
develop
fe
affect
ciclesonid
prophylaxi
mean
valu
arteri
blood
partial
pressur
oxygen
shown
tabl
clinic
observ
made
group
hour
shown
tabl
statist
signific
differ
valu
partial
pressur
oxygen
hourli
interv
hour
two
group
fourteen
case
clinic
subclin
fe
control
group
nine
case
ciclesonid
group
follow
total
durat
episod
hypoxemia
defin
arteri
partial
pressur
oxygen
less
mm
hg
total
length
hypoxemia
hour
ciclesonid
group
hour
control
group
found
statist
signific
one
patient
ciclesonid
prophylaxi
group
two
patient
control
group
requir
ventilatori
support
eventu
patient
recov
well
mortal
either
group
fe
one
lead
caus
morbid
mortal
follow
skelet
trauma
particularli
long
bone
pelvic
fractur
symptom
fe
includ
triad
respiratori
failur
sensori
disturb
petechia
major
mortal
prevent
diagnos
earli
treatment
initi
time
manner
corticosteroid
extens
studi
prophylaxi
fe
evid
regard
efficaci
safeti
strong
enough
recommend
routin
use
lowdos
corticosteroid
given
skelet
trauma
seen
prophylact
effect
incid
fe
arteri
hypoxemia
mostli
act
antiinflammatori
agent
reduc
perivascular
hemorrhag
edema
result
pulmonari
parenchym
injuri
respons
lipid
metabolit
corticosteroid
use
primarili
limit
fear
system
side
effect
associ
usag
metabol
derang
delay
wound
heal
increas
risk
infect
troublesom
surgeon
due
apprehens
complic
system
use
steroid
use
prophylaxi
fe
still
limit
aerosol
therapi
modal
drug
administr
main
advantag
given
therapeut
respons
drug
dose
severalfold
lower
system
absorpt
neglig
howev
year
ago
aerosol
steroid
therapi
effect
bronchial
level
discoveri
ciclesonid
reach
lung
parenchyma
effect
achiev
alveolar
level
efficaci
inhal
corticosteroid
alreadi
clinic
prove
chlorin
gasinduc
lung
injuri
acut
respiratori
distress
syndrom
due
sepsi
fe
also
primarili
lung
parenchyma
disord
hypothes
studi
ciclesonid
aerosol
given
prophylaxi
may
abl
stabil
lung
parenchyma
thu
abl
bear
effect
posttraumat
fat
globulinemia
could
prevent
develop
hypoxemia
fat
embol
syndrom
patient
high
risk
complic
still
studi
regard
role
inhal
steroid
prophylaxi
posttraumat
hypoxia
fat
embol
syndrom
literatur
ciclesonid
highli
potent
rel
safe
inhal
corticosteroid
also
advantag
low
oral
bioavail
inhal
ciclesonid
shown
free
system
side
effect
use
manag
asthma
even
high
dose
dose
mcg
employ
treatment
bronchial
asthma
ciclesonid
dose
mcg
equival
mcg
fluticason
potent
inhal
corticosteroid
patient
studi
group
three
schonfeld
score
equal
indic
clinic
fat
embol
syndrom
six
other
subclin
fat
embol
syndrom
intermitt
episod
signific
hypoxia
score
wherea
group
eight
patient
clinic
fat
embol
syndrom
six
other
subclin
episod
hypoxia
best
knowledg
first
studi
examin
role
inhal
corticosteroid
prophylaxi
posttraumat
subclin
clinic
fe
although
biolog
plausibl
inhal
steroid
may
use
shown
studi
intraven
steroid
literatur
well
trend
seen
possibl
prevent
efficaci
inhal
steroid
present
studi
reach
statist
signific
level
studi
possibl
explan
could
true
inefficaci
inhal
steroid
small
number
patient
studi
effect
may
less
pronounc
intraven
steroid
studi
power
detect
therefor
larger
studi
group
may
requir
defin
precis
role
inhal
steroid
prophylaxi
posttraumat
subclin
clinic
fe
moreov
etiolog
pathogenesi
fe
still
certain
may
factor
also
contribut
result
though
number
patient
present
studi
small
observ
prophylact
role
inhal
steroid
ie
ciclesonid
posttraumat
clinic
subclin
fe
statist
insignific
statist
signific
found
eventu
outcom
subclin
clinic
fat
embol
syndrom
ciclesonid
prophylaxi
control
group
although
trend
seen
possibl
prevent
efficaci
inhal
steroid
present
studi
reach
statist
signific
level
